Table 2 Primary and secondary outcomes
PIFB + RSB group (n = 27) | PIFB group (n = 27) | p | |
|---|---|---|---|
Opioid consumption within 24hs, Mean ± SD, mg | 2.33 ± 1.77 | 3.81 ± 2.24 | 0.010* |
Opioid consumption within 48hs, Mean ± SD, mg | 4.71 ± 2.71 | 7.25 ± 3.76 | 0.006* |
Intraoperative sufentanil consumption, Mean ± SD, μg | 166.30 ± 40.54 | 163.70 ± 41.06 | 0.816 |
Moderate to severe pain, n (%) | 5 (18.5) | 10 (37.0) | 0.129 |
Pain at the chest tube within 48 h, n (%) | 4 (14.8) | 8 (29.6) | 0.190 |
Adverse events with opioid, n (%) | 8 (29.6) | 9 (33.3) | 0.770 |
nausea and vomiting | 6 (22.2) | 6 (22.2) | 1.000 |
pruritus | 0 (0) | 1 (3.7) | - |
urinary retention | 1 (3.7) | 0 (0) | - |
dizziness | 1 (3.7) | 2 (7.4) | 1.000 |
Creatine kinase-MB at 24 h, median (IQR), ng/ml | 6.50 (3.00–19.40) | 7.10 (2.40–20.90) | 0.842 |
Cardiac troponin I at 24 h, median (IQR), pg/ml | 1074.10 (240.30–4076.20) | 878.80 (347.40–5013.70) | 0.829 |
Time to extubation, Mean ± SD, hour | 9.12 ± 5.10 | 9.90 ± 5.06 | 0.578 |
Length of stay in ICU, Mean ± SD, hour | 53.51 ± 40.48 | 52.76 ± 43.87 | 0.949 |
Time to drainage removal, Mean ± SD, hour | 78.14 ± 23.31 | 77.21 ± 20.03 | 0.876 |
Time to catheter removal, Mean ± SD, hour | 91.18 ± 35.02 | 95.31 ± 37.06 | 0.675 |
Able to ambulate after surgery, Mean ± SD, hour | 92.42 ± 37.07 | 92.33 ± 38.63 | 0.993 |
Length of hospital stay, Mean ± SD, day | 12.22 ± 6.62 | 12.56 ± 6.28 | 0.850 |
Mortality within 30 days after surgery, n (%) | 0 (0) | 0 (0) | - |
Chronic pain at three months, n (%) | 5 (18.5) | 7 (25.9) | 0.513 |